Rigel Pharma (RIGL) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $36.74 -0.22%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of $0.04, $0.12 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $26.89 million versus the consensus estimate of $25.7 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Choiceone Financial Services, Inc. (COFS) Misses Q2 EPS by 5c
- Charter Communications (CHTR) Tops Q2 EPS by 66c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
